-
November 16, 2022
Global Mo-99 and I-131 Production Impacted by delay of BR2 Reactor Restarting
Nuclear Medicine Europe has reported a shortage of molybdenum-99 (Mo-99)/technetium-99m (Tc-99m) through and beyond the third week of November.
Read More -
January 26, 2022
Alert: HFR Outage Will Impact Isotope Supply
NMEU COMMUNICATION 24 JAN 2022 Z January 26, 2022 On January 24, the Emergency Response Team (ERT) of Nuclear Medicine Europe (NMEu) communicated that there will be a delay in the restart of the HFR Reactor that will impact the supply of Mo-99 and Lu-177 in coming weeks. The delay is due to discovery of […]
Read More -
April 16, 2020
Update on the Radioisotopes Supply
The Security of Supply Working Group (SoS WG) Emergency Response Team (ERT) held a teleconference on 15 April 2020 to discuss the impact of the COVID-19 pandemic on Mo-99 and other radioisotope production. All organizations again reported that production operations continue normally within adjustments that have been taken against COVID-19, although production is being oriented […]
Read More -
December 5, 2017
Halt to production at NTP Radioisotopes
There is currently a halt to production at NTP Radioisotopes. The Canadian Association of Radiopharmaceutical Scientists (CARS) would like to assess the impact of this production halt on the Canadian radiopharmaceutical community…
Read More -
November 22, 2017
Halt to production ordered at NTP Radioisotopes by TIMESLIVE
A halt to production at NTP Radioisotopes‚ a subsidiary of the South African Nuclear Energy Corporation (Necsa)‚ has been ordered after it discovered procedural deviations related…
Read More -
September 26, 2017
Radioisotope supplies stable but still vulnerable
The IAEA event examined the current supply scenario for molybdenum-99 (Mo-99) and its daughter isotope, technetium-99m (Tc-99m) and alternative production…
Read More
Join us as a member
Filled out our membership form and join CARS Membership today for more radiopharmaceutical and scientific knowledge.